◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›REGN

REGN (REGN)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

MT Newswires·vor 2 Std.

Alnylam Initiates Mid-Stage Study of Mivelsiran in Down Syndrome-Associated Alzheimer's

StockStory·vor 1 Tagen

1 Large-Cap Stock with Exciting Potential and 2 We Turn Down

Trefis·vor 1 Tagen

Own Regeneron For Biotech Growth? Incyte Is Making Its Case.

Insider Monkey·vor 1 Tagen

Disappointing Trial Results Hurt Regeneron Pharmaceuticals (REGN) in Q2

MT Newswires·vor 6 Tagen

Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855

MT Newswires·vor 6 Tagen

Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says

Frag BlackSpecter AI über REGN

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist REGN kaufenswert?REGN Earnings Analyse REGN Bewertung

AI Chat öffnen →